SoftOx enters a 6 billion animal health market
Merkur Market-listed SoftOx will revolutionise wound care for animals and estimates a market potential at NOK 6 billion. The company hopes to achieve a double-digit billion turnover in five years.
The medtech Company, SoftOx will enter into a distribution agreement on animal health with VESO, a supplier of vaccines and medicines for animal health. The agreement stipulates that VESO will distribute SoftOx’s new product line, EffectVet for disinfection and wound treatment in the animal health market.
Read the whole article on Finansavisen.no